Alliance for Clinical Trials in Oncology
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
- First Posted Date
- 2004-01-13
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 150
- Registration Number
- NCT00075855
- Locations
- ๐บ๐ธ
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
๐บ๐ธMedcenter One Health System, Bismarck, North Dakota, United States
๐บ๐ธCCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
- Conditions
- Interventions
- First Posted Date
- 2004-01-13
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 227
- Registration Number
- NCT00075842
- Locations
- ๐บ๐ธ
Fairview Southdale Hospital, Edina, Minnesota, United States
๐บ๐ธSt. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
๐บ๐ธVirginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-01-01
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 42
- Registration Number
- NCT00009893
- Locations
- ๐บ๐ธ
CCOP - Carle Cancer Center, Urbana, Illinois, United States
๐บ๐ธSiouxland Hematology-Oncology, Sioux City, Iowa, United States
๐บ๐ธMedcenter One Health System, Bismarck, North Dakota, United States
Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer
- First Posted Date
- 2003-12-23
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 53
- Registration Number
- NCT00005963
- Locations
- ๐บ๐ธ
CCOP - Duluth, Duluth, Minnesota, United States
๐บ๐ธSiouxland Hematology-Oncology, Sioux City, Iowa, United States
๐บ๐ธCentraCare Clinic, Saint Cloud, Minnesota, United States
Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2003-12-17
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 36
- Registration Number
- NCT00005646
- Locations
- ๐บ๐ธ
Medical University of South Carolina, Charleston, South Carolina, United States
๐บ๐ธState University of New York - Upstate Medical University, Syracuse, New York, United States
๐บ๐ธEllis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 39
- Registration Number
- NCT00074035
- Locations
- ๐บ๐ธ
University of Illinois Cancer Center, Chicago, Illinois, United States
๐บ๐ธWestern Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธTunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 86
- Registration Number
- NCT00004857
- Locations
- ๐บ๐ธ
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
๐บ๐ธVeterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
- Conditions
- Interventions
- First Posted Date
- 2003-11-26
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 366
- Registration Number
- NCT00003387
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
๐บ๐ธUniversity of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
๐บ๐ธUniversity of California San Diego Cancer Center, La Jolla, California, United States
Paclitaxel in Treating Women With Recurrent Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2003-11-25
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 32
- Registration Number
- NCT00003130
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
๐บ๐ธEllis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
- Conditions
- Interventions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1
- Registration Number
- NCT00072215
- Locations
- ๐บ๐ธ
Broward General Medical Center, Fort Lauderdale, Florida, United States
๐บ๐ธMemorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
๐บ๐ธPalm Beach Cancer Institute - West Palm Beach, West Palm Beach, Florida, United States